AI assistant
Cardlytics, Inc. — Director's Dealing 2019
Dec 18, 2019
33956_dirs_2019-12-18_bd68eb30-4e37-4e9f-81af-14bb7ac48e28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2019-12-16
Reporting Person: SOMERS KIRK (Chief Legal & Privacy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-16 | Common Stock | M | 777 | $9.08 | Acquired | 84070 | Direct |
| 2019-12-16 | Common Stock | M | 261 | $20 | Acquired | 84331 | Direct |
| 2019-12-16 | Common Stock | M | 10000 | $30.44 | Acquired | 94331 | Direct |
| 2019-12-16 | Common Stock | S | 11038 | $58 | Disposed | 83293 | Direct |
| 2019-12-17 | Common Stock | G | 200 | — | Disposed | 83093 | Direct |
| 2019-12-17 | Common Stock | G | 200 | — | Disposed | 82893 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-16 | Employee Stock Option (Right to Buy) | $9.08 | M | 777 | Disposed | 2024-08-01 | Common Stock (777.0) | Direct |
| 2019-12-16 | Employee Stock Option (Right to Buy) | $20.0 | M | 261 | Disposed | 2026-12-06 | Common Stock (261.0) | Direct |
| 2019-12-16 | Employee Stock Option (Right to Buy) | $30.44 | M | 10000 | Disposed | 2027-07-07 | Common Stock (10000.0) | Direct |
Footnotes
F1: Shares transferred by the Reporting Person as a bona fide gift without consideration.
F2: Fully vested.
F3: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.
F4: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.